NEWS & EVENTS

The Synapmed Insights Center offers expert perspectives and strategies to help biopharma and life sciences companies confidently navigate drug development and commercialization.

News

June 20, 2023

Synapmed Announces Growing Prominence of Adverse Event Signal Detection Platform

NEW YORK, June 20, 2023 /PRNewswire/ — AstaLynx Global is pleased to announce the growing prominence of its proprietary signal detection and management system, ADRium-Signals™. Over the last 12 months, ADRium-Signals has replaced two of the top leading legacy signal detection systems at several midsize pharmaceutical companies. ADRium Signals has been selected by these companies...

Dedicated to youR Projects

No matter the size or scope of your projects, you have a committed partnership team with Synapmed. We’re a team that listens, pays attention to details, and brings smart insights to the table. We do it all so you can solve real problems throughout the product development and commercialization lifecycle.